Cervarix™ – a bivalent L1 virus-like particle vaccine for prevention of human papillomavirus type 16- and 18-associated cervical cancer

By Crosbie Emma J   Kitchener Henry C  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 3, 2007-03 ,pp. : 391-396

Informa Healthcare

Access to resources Recommend Favorite

α₆ Integrin Is the Main Receptor of Human Papillomavirus Type 16 VLP

By Yoon C-S.   Kim K-D.   Park S-N.   Cheong S-W.  

Biochemical and Biophysical Research Communications, Vol. 283, Iss. 3, 2001-05 ,pp. : 668-673

Elsevier

Access to resources Recommend Favorite

Differential Effects of Progestins and Estrogens on Long Control Regions of Human Papillomavirus Types 16 and 18

By Chen Y.H.   Huang L.H.   Chen T.M.  

Biochemical and Biophysical Research Communications, Vol. 224, Iss. 3, 1996-07 ,pp. : 651-659

Elsevier

Access to resources Recommend Favorite

Replication-Associated Activities of Purified Human Papillomavirus Type 11 E1 Helicase

By Rocque W.J.   Porter D.J.T.   Barnes J.A.   Dixon E.P.   Lobe D.C.   Su J-L.   Willard D.H.   Gaillard R.   Condreay J.P.   Clay W.C.   Hoffman C.R.   Overton L.K.   Pahel G.   Kost T.A.   Phelps W.C.  

Protein Expression and Purification, Vol. 18, Iss. 2, 2000-03 ,pp. : 148-159

Academic Press

Access to resources Recommend Favorite

Bacterial Expression and Immunological Detection of Human Papillomavirus Type 16 E7 Protein

By Moro A.   Hernandez P.  

Biochemical and Biophysical Research Communications, Vol. 226, Iss. 3, 1996-09 ,pp. : 895-899

Elsevier

Access to resources Recommend Favorite